Cellular prion protein is present in dopaminergic neurons and modulates the dopaminergic system

European Journal of Neuroscience

Volumn 40, Issue 3, 2014, Pages 2479-2486

  Rial, Daniel ^a,b   Pamplona, Fabrício A ^a,c   Moreira, Eduardo L G ^a   Moreira, Karin M ^d   Hipolide, Débora ^d   Rodrigues, Diana I ^b   Dombrowski, Patrícia A ^e   Da Cunha, Claudio ^e   Agostinho, Paula ^b,f   Takahashi, Reinaldo N ^a   Walz, Roger ^a,g   Cunha, Rodrigo A ^b,f   Prediger, Rui D ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^f UNIVERSITY OF COIMBRA   (Portugal)

^g HOSPITAL GOVERNADOR CELSO RAMOS   (Brazil)

Author keywords

Behavior; Cellular prion protein; Dopamine; Dopamine receptor; Striatum

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; PHOSPHOPROTEIN DARPP 32; PRION PROTEIN; DOPAMINE D1A RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DOWN REGULATION; EMBRYO; FEMALE; IN VITRO STUDY; MOUSE; NERVE CELL CULTURE; NERVE CELL MEMBRANE; NERVE ENDING; NEUROMODULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SYNAPSE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOTOR ACTIVITY; NEOSTRIATUM; PHYSIOLOGY;

ANIMALS; DOPAMINE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; DOPAMINERGIC NEURONS; FEMALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NEOSTRIATUM; PREFRONTAL CORTEX; PRPC PROTEINS; RECEPTORS, DOPAMINE D1;

EID: 84905364655     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12600     Document Type: Article

References (32)

1. Amenta, D., Cavallotti, C. & Amenta, F. (1987) Dopamine receptors mediating the stimulation and the inhibition of adenylate cyclase in rat prostate gland. Neurosci. Lett., 77, 66-70.
2. Bueler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.P., DeArmond, S.J., Prusiner, S.B., Aguet, M. & Weissmann, C. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature, 356, 577-582.
3. Canas, P.M., Simões, A.P., Rodrigues, R.J. & Cunha, R.A. (2014) Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease. Neuropharmacology, 76, 51-56.
4. Collinge, J., Whittington, M.A., Sidle, K.C., Smith, C.J., Palmer, M.S., Clarke, A.R. & Jefferys, J.G. (1994) Prion protein is necessary for normal synaptic function. Nature, 370, 295-297.
5. Costes, S.V., Daelemans, D., Cho, E.H., Dobbin, Z., Pavlakis, G. & Lockett, S. (2004) Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J., 86, 3993-4003.
6. Criado, J.R., Sanchez-Alavez, M., Conti, B., Giacchino, J.L., Wills, D.N., Henriksen, S.J., Race, R., Manson, J.C., Chesebro, B. & Oldstone, M.B. (2005) Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol. Dis., 19, 255-265.
7. Fath, T., Ke, Y.D., Gunning, P., Gotz, J. & Ittner, L.M. (2009) Primary support cultures of hippocampal and substantia nigra neurons. Nat. Protoc., 4, 78-85.
8. Fetsko, L.A., Xu, R. & Wang, Y. (2003) Alterations in D1/D2 synergism may account for enhanced stereotypy and reduced climbing in mice lacking dopamine D2L receptor. Brain Res., 967, 191-200.
9. Fienberg, A.A., Hiroi, N., Mermelstein, P.G., Song, W., Snyder, G.L., Nishi, A., Cheramy, A., O'Callaghan, J.P., Miller, D.B., Cole, D.G., Corbett, R., Haile, C.N., Cooper, D.C., Onn, S.P., Grace, A.A., Ouimet, C.C., White, F.J., Hyman, S.E., Surmeier, D.J., Girault, J., Nestler, E.J. & Greengard, P. (1998) DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science, 281, 838-842.
10. Ford, M.J., Burton, L.J., Li, H., Graham, C.H., Frobert, Y., Grassi, J., Hall, S.M. & Morris, R.J. (2002) A marked disparity between the expression of prion protein and its message by neurones of the CNS. Neuroscience, 111, 533-551.
11. Fournier, J.G., Escaig-Haye, F., Billette de Villemeur, T. & Robain, O. (1995) Ultrastructural localization of cellular prion protein (PrPc) in synaptic boutons of normal hamster hippocampus. C. R. Acad. Sci., 318, 339-344.
12. Freundt, E.C., Maynard, N., Clancy, E.K., Roy, S., Bousset, L., Sourigues, Y., Covert, M., Melki, R., Kirkegaard, K. & Brahic, M. (2012) Neuron-to-neuron transmission of alpha-synuclein fibrils through axonal transport. Ann. Neurol., 72, 517-524.
13. Khosravani, H., Zhang, Y., Tsutsui, S., Hameed, S., Altier, C., Hamid, J., Chen, L., Villemaire, M., Ali, Z., Jirik, F.R. & Zamponi, G.W. (2008) Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J. Cell Biol., 181, 551-565.
14. Kunii, Y., Hyde, T.M., Ye, T., Li, C., Kolachana, B., Dickinson, D., Weinberger, D.R., Kleinman, J.E. & Lipska, B.K. (2014) Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression. Mol. Psychiatr., 19, 192-199.
15. Lee, H.G., Park, S.J., Choi, E.K., Carp, R.I. & Kim, Y.S. (1999) Increased expression of prion protein is associated with changes in dopamine metabolism and MAO activity in PC12 cells. J. Mol. Neurosci., 13, 121-126.
16. Linden, R., Martins, V.R., Prado, M.A., Cammarota, M., Izquierdo, I. & Brentani, R.R. (2008) Physiology of the prion protein. Physiol. Rev., 88, 673-728.
17. Lindgren, N., Usiello, A., Goiny, M., Haycock, J., Erbs, E., Greengard, P., Hokfelt, T., Borrelli, E. & Fisone, G. (2003) Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc. Natl. Acad. Sci. USA, 100, 4305-4309.
18. Medeiros, R., Prediger, R.D., Passos, G.F., Pandolfo, P., Duarte, F.S., Franco, J.L., Dafre, A.L., Di Giunta, G., Figueiredo, C.P., Takahashi, R.N., Campos, M.M. & Calixto, J.B. (2007) Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein. J. Neurosci., 27, 5394-5404.
19. Mollenhauer, B., Cullen, V., Kahn, I., Krastins, B., Outeiro, T.F., Pepivani, I., Ng, J., Schulz-Schaeffer, W., Kretzschmar, H.A., McLean, P.J., Trenkwalder, C., Sarracino, D.A., Vonsattel, J.P., Locascio, J.J., El-Agnaf, O.M. & Schlossmacher, M.G. (2008) Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp. Neurol., 213, 315-325.
20. Olanow, C.W. & Prusiner, S.B. (2009) Is Parkinson's disease a prion disorder? Proc. Natl. Acad. Sci. USA, 106, 12571-12572.
21. Paxinos, G. & Franklin, K.B. (2001) The mouse brain in stereotaxic coordinates. Academic Press, San Diego.
22. Plate, A., Benninghoff, J., Jansen, G.H., Wlasich, E., Eigenbrod, S., Drzezga, A., Jansen, N.L., Kretzschmar, H.A., Botzel, K., Rujescu, D. & Danek, A. (2013) Atypical parkinsonism due to a D202N Gerstmann-Straussler-Scheinker prion protein mutation: first in vivo diagnosed case. Movement Disord., 28, 241-244.
23. Protais, P., Costentin, J. & Schwartz, J.C. (1976) Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology, 50, 1-6.
24. Rebola, N., Pinheiro, P.C., Oliveira, C.R., Malva, J.O. & Cunha, R.A. (2003) Subcellular localization of adenosine A1 receptors in nerve terminals and synapses of the rat hippocampus. Brain Res., 987, 49-58.
25. Rial, D., Duarte, F.S., Xikota, J.C., Schmitz, A.E., Dafre, A.L., Figueiredo, C.P., Walz, R. & Prediger, R.D. (2009) Cellular prion protein modulates age-related behavioral and neurochemical alterations in mice. Neuroscience, 164, 896-907.
26. Rodrigues, R.J., Canas, P.M., Lopes, L.V., Oliveira, C.R. & Cunha, R.A. (2008) Modification of adenosine receptor modulation of acetylcholine release in the hippocampus of aged rats. Neurobiol. Aging, 29, 1597-1601.
27. Sales, N., Rodolfo, K., Hassig, R., Faucheux, B., Di Giamberardino, L. & Moya, K.L. (1998) Cellular prion protein localization in rodent and primate brain. Eur. J. Neurosci., 10, 2464-2471.
28. Svenningsson, P., Nishi, A., Fisone, G., Girault, J.A., Nairn, A.C. & Greengard, P. (2004) DARPP-32: an integrator of neurotransmission. Annu. Rev. Pharmacol., 44, 269-296.
29. Tadaiesky, M.T., Dombrowski, P.A., Figueiredo, C.P., Cargnin-Ferreira, E., Da Cunha, C. & Takahashi, R.N. (2008) Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease. Neuroscience, 156, 830-840.
30. Tritsch, N.X. & Sabatini, B.L. (2012) Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron, 76, 33-50.
31. Walz, R., Amaral, O.B., Rockenbach, I.C., Roesler, R., Izquierdo, I., Cavalheiro, E.A., Martins, V.R. & Brentani, R.R. (1999) Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia, 40, 1679-1682.
32. c) in schizophrenia, bipolar disorder, and depression. J. Neural Transm., 115, 761-771.